Innovations in surgery, biologics, and AI are shaping the future of eye aesthetics.
On the Orbital Edge
Advertisement
Understand the anatomical risks, technique-specific benefits, and patient selection criteria
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
3
PainReform launches development plan for OcuRing-K, readies phase 2 trial
4
First patient treated in ViaLase’s IDE trial
5
.png "Optometry Times"){kind=logo}
